Heterotopic caval valve implantation in severe tricuspid regurgitation

Neeraj Sharma; Nagendra Chouhan; Manish Bansal; Praveen Chandra; Ajmer Singh; Rajiv Juneja; Yatin Mehta; Naresh Trehan

doi:10.4103/aca.ACA_72_20

Heterotopic caval valve implantation in severe tricuspid regurgitation

Neeraj Sharma, Nagendra Chouhan, Manish Bansal, Praveen Chandra, Ajmer Singh, Rajiv Juneja, Yatin Mehta, Naresh Trehan

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

2 Downloads (Pure)

Abstract

Severe symptomatic tricuspid regurgitation (TR) with right heart failure is associated with significant morbidity and mortality. Medical therapy is often ineffective and surgical correction is not feasible due to prohibitive perioperative risk. Transcatheter caval valve implantation (CAVI) is an evolving therapeutic option for this condition. It refers to the heterotopic placement of a valve into the inferior vena cava alone or with a second valve in the superior vena cava to restrict the backflow from the failing tricuspid valve. We hereby describe a patient with previous mitral valve surgery with chronic severe TR who underwent successful CAVI at our institute.

Original language	English
Pages (from-to)	365-368
Number of pages	4
Journal	Annals of Cardiac Anaesthesia
Volume	24
Issue number	3
DOIs	https://doi.org/10.4103/aca.ACA_72_20
Publication status	Published - Jul 2021
Externally published	Yes

Keywords

Caval valve implantation
structural heart disease intervention
transcatheter therapy
tricuspid regurgitation

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.4103/aca.ACA_72_20Licence: CC BY-NC-SA

Published versionFinal published version, 1.19 MBLicence: CC BY-NC-SA

Cite this

@article{a3cb12089a67409fbaa40bdfbbf03188,

title = "Heterotopic caval valve implantation in severe tricuspid regurgitation",

abstract = "Severe symptomatic tricuspid regurgitation (TR) with right heart failure is associated with significant morbidity and mortality. Medical therapy is often ineffective and surgical correction is not feasible due to prohibitive perioperative risk. Transcatheter caval valve implantation (CAVI) is an evolving therapeutic option for this condition. It refers to the heterotopic placement of a valve into the inferior vena cava alone or with a second valve in the superior vena cava to restrict the backflow from the failing tricuspid valve. We hereby describe a patient with previous mitral valve surgery with chronic severe TR who underwent successful CAVI at our institute.",

keywords = "Caval valve implantation, structural heart disease intervention, transcatheter therapy, tricuspid regurgitation",

author = "Neeraj Sharma and Nagendra Chouhan and Manish Bansal and Praveen Chandra and Ajmer Singh and Rajiv Juneja and Yatin Mehta and Naresh Trehan",

year = "2021",

month = jul,

doi = "10.4103/aca.ACA_72_20",

language = "English",

volume = "24",

pages = "365--368",

journal = "Annals of Cardiac Anaesthesia",

issn = "0971-9784",

publisher = "Medknow Publications and Media Pvt. Ltd.",

number = "3",

}

TY - JOUR

T1 - Heterotopic caval valve implantation in severe tricuspid regurgitation

AU - Sharma, Neeraj

AU - Chouhan, Nagendra

AU - Bansal, Manish

AU - Chandra, Praveen

AU - Singh, Ajmer

AU - Juneja, Rajiv

AU - Mehta, Yatin

AU - Trehan, Naresh

PY - 2021/7

Y1 - 2021/7

N2 - Severe symptomatic tricuspid regurgitation (TR) with right heart failure is associated with significant morbidity and mortality. Medical therapy is often ineffective and surgical correction is not feasible due to prohibitive perioperative risk. Transcatheter caval valve implantation (CAVI) is an evolving therapeutic option for this condition. It refers to the heterotopic placement of a valve into the inferior vena cava alone or with a second valve in the superior vena cava to restrict the backflow from the failing tricuspid valve. We hereby describe a patient with previous mitral valve surgery with chronic severe TR who underwent successful CAVI at our institute.

AB - Severe symptomatic tricuspid regurgitation (TR) with right heart failure is associated with significant morbidity and mortality. Medical therapy is often ineffective and surgical correction is not feasible due to prohibitive perioperative risk. Transcatheter caval valve implantation (CAVI) is an evolving therapeutic option for this condition. It refers to the heterotopic placement of a valve into the inferior vena cava alone or with a second valve in the superior vena cava to restrict the backflow from the failing tricuspid valve. We hereby describe a patient with previous mitral valve surgery with chronic severe TR who underwent successful CAVI at our institute.

KW - Caval valve implantation

KW - structural heart disease intervention

KW - transcatheter therapy

KW - tricuspid regurgitation

UR - http://www.scopus.com/inward/record.url?scp=85111067720&partnerID=8YFLogxK

U2 - 10.4103/aca.ACA_72_20

DO - 10.4103/aca.ACA_72_20

M3 - Article

C2 - 34269270

AN - SCOPUS:85111067720

SN - 0971-9784

VL - 24

SP - 365

EP - 368

JO - Annals of Cardiac Anaesthesia

JF - Annals of Cardiac Anaesthesia

IS - 3

ER -

Heterotopic caval valve implantation in severe tricuspid regurgitation

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this